Markets Stocks Economy Crypto Earnings Banking Energy
Home Tech Feature
Tech · Exclusive

Unitree prices Shanghai IPO at 150.8 yuan, valuing humanoid robot maker at 61 billion yuan

Unitree prices Shanghai IPO at 150.8 yuan, valuing humanoid robot maker at 61 billion yuan
Tech · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Aug 6, 2026 4 min read

Unitree, the Hangzhou-based company known for its humanoid and four-legged robots, has set the price for its initial public offering on Shanghai's STAR Market. The company will sell shares at 150.8 yuan each, giving it a market valuation of about 61 billion yuan (roughly $8.5 billion). The listing is one of the most anticipated tech IPOs in China this year, as investors bet on the rapid growth of humanoid robotics.

What's driving the valuation?

Unitree's revenue more than quadrupled to 1.7 billion yuan in the latest reported period, a surge that reflects strong demand for its robots. Notably, sales of its humanoid robots reached 867.8 million yuan, surpassing revenue from its four-legged robot line. That shift is significant: it signals that humanoid robots are moving from novelty to commercial viability, a trend that has captured the attention of both tech enthusiasts and institutional investors.

The STAR Market, launched in 2019, is China's answer to Nasdaq, designed to attract innovative tech companies. Listing there gives Unitree access to deep capital pools and a valuation that might not be available elsewhere. For Chinese tech firms, a domestic listing also reduces exposure to US regulatory and political risks.

US-China tensions cast a shadow

While the IPO price is a milestone, the company faces a potential headwind: escalating trade and technology tensions between the US and China. These tensions could crimp Unitree's future sales in the US, which has been a key market for its robots. The US has already restricted some Chinese tech exports, and further restrictions could limit Unitree's ability to sell its products to American customers, especially in sectors like defense and public safety.

This is not just a Unitree problem. Many Chinese tech companies are navigating a similar landscape, balancing domestic growth with international ambitions. The broader context is that US-China tech rivalry has intensified, affecting everything from chip exports to AI development. As ByteDance's founder recently urged staff to avoid AI shortcuts, the pressure on Chinese tech firms to innovate independently has grown.

What this means for investors

For everyday investors, the Unitree IPO offers a chance to own a piece of a fast-growing robotics company, but it comes with risks. The valuation of 61 billion yuan is steep, especially for a company that, while growing quickly, still has a relatively small revenue base. Investors are paying a premium for future growth, and that growth depends on both technological success and the ability to sell globally.

The humanoid robot market is still in its early stages. While companies like Unitree are making strides, mass adoption is years away. That means the stock could be volatile, and the company's fortunes could swing with news about trade policy or technological breakthroughs.

For those considering investing, it's important to understand that IPOs on the STAR Market are subject to different rules than US listings. The STAR Market allows companies with less stringent profitability requirements, which can mean higher risk. Also, Chinese stocks are often influenced by domestic policy and market sentiment, which can differ from global trends.

The broader tech sector has been under pressure recently, as emerging market stocks slipped as Asian chipmakers cooled off. That cooling could spill over to robotics, but Unitree's strong revenue growth might help it buck the trend.

Looking ahead

Unitree's listing is a test of investor appetite for humanoid robotics. If the stock performs well, it could encourage other Chinese robotics startups to go public. If it stumbles, it might signal that the hype has outpaced reality.

For now, the company's focus on humanoid robots—which are designed to work alongside humans in factories, homes, and other settings—positions it at the forefront of a technological shift. But as with any early-stage technology, the path to profitability is uncertain.

Investors should also keep an eye on how US-China relations evolve. Any new tariffs or export controls could directly affect Unitree's ability to sell in the US, which has been a significant market. The company's future may depend as much on geopolitics as on engineering.

In the meantime, the IPO is a reminder that the robotics race is heating up, and that Chinese companies are determined to lead. Whether that leadership translates into shareholder value remains to be seen.

More from this story

Next article · Don't miss

Asia ADRs edge up as Zai Lab surges 12.8%, Jiayin drops 12%

The S&P Asia 50 ADR Index rose 0.55% in early US trading, but the real moves were in individual stocks: Zai Lab surged 12.8% while Jiayin Group tumbled 12%. Here's what's driving the divergence and what it means for ADR investors.

Read the story →
Asia ADRs edge up as Zai Lab surges 12.8%, Jiayin drops 12%